Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of B cell differentiation (GO:0045579) | 4.99268975 |
2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.98211765 |
3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.87467176 |
4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.87467176 |
5 | ribosomal small subunit assembly (GO:0000028) | 4.63260480 |
6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.57659816 |
7 | positive regulation of mast cell activation (GO:0033005) | 4.52217535 |
8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.50263249 |
9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.50263249 |
10 | modulation by symbiont of host immune response (GO:0052553) | 4.50263249 |
11 | positive regulation by symbiont of host defense response (GO:0052509) | 4.50263249 |
12 | modulation by symbiont of host defense response (GO:0052031) | 4.50263249 |
13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.50263249 |
14 | B cell receptor signaling pathway (GO:0050853) | 4.33683395 |
15 | cellular extravasation (GO:0045123) | 4.31241379 |
16 | negative regulation of phagocytosis (GO:0050765) | 4.29178841 |
17 | definitive hemopoiesis (GO:0060216) | 4.14884568 |
18 | positive regulation of mast cell degranulation (GO:0043306) | 3.89447565 |
19 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.89447565 |
20 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.87026730 |
21 | regulation of B cell differentiation (GO:0045577) | 3.84821088 |
22 | granulocyte activation (GO:0036230) | 3.83807775 |
23 | negative regulation of interleukin-12 production (GO:0032695) | 3.83677444 |
24 | macrophage activation involved in immune response (GO:0002281) | 3.82899463 |
25 | microglial cell activation (GO:0001774) | 3.77323232 |
26 | regulation of mast cell activation (GO:0033003) | 3.76926388 |
27 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.70635805 |
28 | negative regulation of cell killing (GO:0031342) | 3.70635805 |
29 | DNA unwinding involved in DNA replication (GO:0006268) | 3.61452970 |
30 | detection of molecule of bacterial origin (GO:0032490) | 3.60395211 |
31 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.59815626 |
32 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.57082399 |
33 | regulation of leukocyte degranulation (GO:0043300) | 3.55538225 |
34 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.54570094 |
35 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.53220505 |
36 | regulation of platelet aggregation (GO:0090330) | 3.50031038 |
37 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.47059091 |
38 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.44981447 |
39 | regulation of gamma-delta T cell activation (GO:0046643) | 3.42401395 |
40 | regulation of histone H3-K9 methylation (GO:0051570) | 3.41126527 |
41 | thrombin receptor signaling pathway (GO:0070493) | 3.38252181 |
42 | T cell homeostasis (GO:0043029) | 3.37967944 |
43 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.36372814 |
44 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.35919343 |
45 | macrophage activation (GO:0042116) | 3.35546743 |
46 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.34330808 |
47 | myeloid cell activation involved in immune response (GO:0002275) | 3.32042689 |
48 | detection of other organism (GO:0098543) | 3.31954586 |
49 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.30169872 |
50 | regulation of platelet activation (GO:0010543) | 3.29400065 |
51 | positive regulation of leukocyte degranulation (GO:0043302) | 3.27461562 |
52 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.27397565 |
53 | response to host immune response (GO:0052572) | 3.27397565 |
54 | megakaryocyte development (GO:0035855) | 3.26077884 |
55 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.23962767 |
56 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.22904840 |
57 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.21558400 |
58 | DNA strand elongation (GO:0022616) | 3.20360253 |
59 | DNA topological change (GO:0006265) | 3.16961294 |
60 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.13932756 |
61 | detection of external biotic stimulus (GO:0098581) | 3.11580234 |
62 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.11082884 |
63 | response to host (GO:0075136) | 3.11082884 |
64 | response to host defenses (GO:0052200) | 3.11082884 |
65 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.09873560 |
66 | protein localization to kinetochore (GO:0034501) | 3.09780221 |
67 | telomere maintenance via recombination (GO:0000722) | 3.09692675 |
68 | response to muramyl dipeptide (GO:0032495) | 3.05954634 |
69 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.04754834 |
70 | mitotic recombination (GO:0006312) | 3.01971360 |
71 | V(D)J recombination (GO:0033151) | 3.00728941 |
72 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.98488113 |
73 | lymphocyte homeostasis (GO:0002260) | 2.97865294 |
74 | detection of bacterium (GO:0016045) | 2.96717470 |
75 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.96257030 |
76 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.91797833 |
77 | positive regulation of granulocyte differentiation (GO:0030854) | 2.88860659 |
78 | cellular hyperosmotic response (GO:0071474) | 2.88804804 |
79 | hepatocyte apoptotic process (GO:0097284) | 2.88702902 |
80 | viral transcription (GO:0019083) | 2.87128995 |
81 | oligosaccharide catabolic process (GO:0009313) | 2.85556436 |
82 | detection of biotic stimulus (GO:0009595) | 2.81050491 |
83 | response to thyroid hormone (GO:0097066) | 2.79801814 |
84 | regulation of regulated secretory pathway (GO:1903305) | 2.79539557 |
85 | neutrophil activation involved in immune response (GO:0002283) | 2.79110747 |
86 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.77848826 |
87 | immunoglobulin mediated immune response (GO:0016064) | 2.77546730 |
88 | positive regulation of type 2 immune response (GO:0002830) | 2.77413302 |
89 | response to peptidoglycan (GO:0032494) | 2.75275777 |
90 | protein localization to chromosome, centromeric region (GO:0071459) | 2.74674217 |
91 | negative regulation of histone methylation (GO:0031061) | 2.74464374 |
92 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.74165876 |
93 | negative regulation of interleukin-17 production (GO:0032700) | 2.73698309 |
94 | translational termination (GO:0006415) | 2.72253879 |
95 | mast cell activation (GO:0045576) | 2.71711800 |
96 | leukocyte aggregation (GO:0070486) | 2.70447150 |
97 | regulation of erythrocyte differentiation (GO:0045646) | 2.70432124 |
98 | leukocyte homeostasis (GO:0001776) | 2.69985303 |
99 | response to protozoan (GO:0001562) | 2.68989337 |
100 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.68553680 |
101 | leukocyte degranulation (GO:0043299) | 2.67689034 |
102 | neutrophil mediated immunity (GO:0002446) | 2.66080541 |
103 | germinal center formation (GO:0002467) | 2.65719301 |
104 | T-helper 1 type immune response (GO:0042088) | 2.65062400 |
105 | angiogenesis involved in wound healing (GO:0060055) | 2.64097461 |
106 | natural killer cell differentiation (GO:0001779) | 2.63801051 |
107 | neutrophil activation (GO:0042119) | 2.63390812 |
108 | natural killer cell activation involved in immune response (GO:0002323) | 2.62715540 |
109 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.62602853 |
110 | positive regulation of regulated secretory pathway (GO:1903307) | 2.62476883 |
111 | defense response to protozoan (GO:0042832) | 2.61657281 |
112 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.61420112 |
113 | positive regulation of macrophage differentiation (GO:0045651) | 2.61364288 |
114 | DNA duplex unwinding (GO:0032508) | 2.61226586 |
115 | myeloid dendritic cell activation (GO:0001773) | 2.59142151 |
116 | DNA replication initiation (GO:0006270) | 2.58933815 |
117 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.58692097 |
118 | superoxide anion generation (GO:0042554) | 2.58578739 |
119 | DNA geometric change (GO:0032392) | 2.58476477 |
120 | regulation of interleukin-17 production (GO:0032660) | 2.57771892 |
121 | platelet aggregation (GO:0070527) | 2.56852540 |
122 | myeloid leukocyte activation (GO:0002274) | 2.56726942 |
123 | negative regulation of T cell mediated immunity (GO:0002710) | 2.54633831 |
124 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.54273629 |
125 | negative regulation of B cell proliferation (GO:0030889) | 2.54031845 |
126 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.52920270 |
127 | translesion synthesis (GO:0019985) | 2.51785997 |
128 | telomere maintenance via telomere lengthening (GO:0010833) | 2.51558736 |
129 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.51244320 |
130 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.50642578 |
131 | B cell homeostasis (GO:0001782) | 2.50377329 |
132 | IMP biosynthetic process (GO:0006188) | 2.49662229 |
133 | histamine secretion (GO:0001821) | 2.49162264 |
134 | glycosphingolipid catabolic process (GO:0046479) | 2.48833323 |
135 | positive regulation of protein deacetylation (GO:0090312) | 2.48760200 |
136 | adenosine receptor signaling pathway (GO:0001973) | 2.48240562 |
137 | respiratory burst (GO:0045730) | 2.47571781 |
138 | translational elongation (GO:0006414) | 2.47535563 |
139 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.47449731 |
140 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.47372215 |
141 | B cell differentiation (GO:0030183) | 2.47116330 |
142 | regulation of hypersensitivity (GO:0002883) | 2.46646610 |
143 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.44168541 |
144 | B cell activation (GO:0042113) | 2.43977019 |
145 | telomere maintenance (GO:0000723) | 2.42780254 |
146 | mitochondrial DNA replication (GO:0006264) | 2.42172621 |
147 | embryonic hemopoiesis (GO:0035162) | 2.41718938 |
148 | negative regulation of RNA splicing (GO:0033119) | 2.41628791 |
149 | erythrocyte maturation (GO:0043249) | 2.41081420 |
150 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.40225974 |
151 | B cell mediated immunity (GO:0019724) | 2.39998197 |
152 | telomere organization (GO:0032200) | 2.38535495 |
153 | pentose-phosphate shunt (GO:0006098) | 2.38276042 |
154 | cotranslational protein targeting to membrane (GO:0006613) | 2.37707335 |
155 | protein targeting to ER (GO:0045047) | 2.37467816 |
156 | pinocytosis (GO:0006907) | 2.36376619 |
157 | response to fungus (GO:0009620) | 2.35863125 |
158 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.35508535 |
159 | response to interferon-beta (GO:0035456) | 2.34894292 |
160 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.34396435 |
161 | regulation of B cell apoptotic process (GO:0002902) | 2.34369666 |
162 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.33923892 |
163 | cellular response to zinc ion (GO:0071294) | 2.33676615 |
164 | dosage compensation (GO:0007549) | 2.33495882 |
165 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.32912430 |
166 | regulation of granulocyte differentiation (GO:0030852) | 2.32783945 |
167 | regulation of DNA endoreduplication (GO:0032875) | 2.32259679 |
168 | regulation of mast cell degranulation (GO:0043304) | 2.32143237 |
169 | mitotic sister chromatid cohesion (GO:0007064) | 2.31080578 |
170 | lymph node development (GO:0048535) | 2.30727299 |
171 | meiotic chromosome segregation (GO:0045132) | 2.30702384 |
172 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.29896133 |
173 | pyrimidine nucleoside salvage (GO:0043097) | 2.29030078 |
174 | pyrimidine-containing compound salvage (GO:0008655) | 2.29030078 |
175 | execution phase of apoptosis (GO:0097194) | 2.28805113 |
176 | B cell proliferation (GO:0042100) | 2.28112127 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.01840908 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.88188225 |
3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.37920670 |
4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.33292562 |
5 | MYC_22102868_ChIP-Seq_BL_Human | 3.23307077 |
6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.05783252 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.03594652 |
8 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.01229605 |
9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.98921808 |
10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.82142319 |
11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.79770583 |
12 | GATA1_19941826_ChIP-Seq_K562_Human | 2.67873847 |
13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.60417645 |
14 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.58862944 |
15 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.56356485 |
16 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.50260011 |
17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.50187651 |
18 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.47754364 |
19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.45401795 |
20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.32397699 |
21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.30865116 |
22 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.27587053 |
23 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.26500342 |
24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15139449 |
25 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.15035947 |
26 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.11566863 |
27 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.11331100 |
28 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10720256 |
29 | * GATA2_19941826_ChIP-Seq_K562_Human | 2.07984568 |
30 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.04371720 |
31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01387250 |
32 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.00881963 |
33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.98965976 |
34 | MYB_26560356_Chip-Seq_TH2_Human | 1.95735979 |
35 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.92136222 |
36 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.90410967 |
37 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.88936021 |
38 | GATA1_22025678_ChIP-Seq_K562_Human | 1.88781155 |
39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.86908891 |
40 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85878631 |
41 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.85356007 |
42 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84547319 |
43 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.82953379 |
44 | MYB_26560356_Chip-Seq_TH1_Human | 1.81453656 |
45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.81014566 |
46 | MAF_26560356_Chip-Seq_TH1_Human | 1.77982726 |
47 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73626682 |
48 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.73020550 |
49 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.72583999 |
50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.71671191 |
51 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.70418339 |
52 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.68273787 |
53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.68086037 |
54 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.63255835 |
55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.61205868 |
56 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.60387159 |
57 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.60220440 |
58 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.59063477 |
59 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.56843656 |
60 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.56662956 |
61 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.54008335 |
62 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.51900633 |
63 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.51889387 |
64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.51021179 |
65 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49964609 |
66 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.49182380 |
67 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.49157069 |
68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47207603 |
69 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.46374417 |
70 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.45012379 |
71 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.44585751 |
72 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.43853838 |
73 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.38481069 |
74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.37225176 |
75 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.35533968 |
76 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.33836491 |
77 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.33576571 |
78 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.32328687 |
79 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.30329371 |
80 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.28918724 |
81 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.24098849 |
82 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.22286359 |
83 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21000806 |
84 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.20542152 |
85 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19330388 |
86 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.19115164 |
87 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.18177121 |
88 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.16938355 |
89 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.16529355 |
90 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.16396380 |
91 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15975269 |
92 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15533099 |
93 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.15253671 |
94 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14185043 |
95 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.14075936 |
96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12204725 |
97 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11180805 |
98 | MAF_26560356_Chip-Seq_TH2_Human | 1.08489332 |
99 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07851292 |
100 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.07389286 |
101 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.05586930 |
102 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.03733274 |
103 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.03698595 |
104 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.02907285 |
105 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02653633 |
106 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02085419 |
107 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01750768 |
108 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.01077135 |
109 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00133293 |
110 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.99464744 |
111 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99014031 |
112 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.98812078 |
113 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98682486 |
114 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97839841 |
115 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97480292 |
116 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.96852336 |
117 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.95973409 |
118 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.95238269 |
119 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.94785300 |
120 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.92972318 |
121 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.92548590 |
122 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92252714 |
123 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.92164712 |
124 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.91046000 |
125 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.90353987 |
126 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88586630 |
127 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.87212967 |
128 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86939805 |
129 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.86361934 |
130 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86228362 |
131 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.85962977 |
132 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.85937859 |
133 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.82700100 |
134 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.82137961 |
135 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.77386666 |
136 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.77211469 |
137 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77164078 |
138 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75812976 |
139 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75755328 |
140 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.74837338 |
141 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.73357096 |
142 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.71494384 |
143 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.70319401 |
144 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68136251 |
145 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.67928675 |
146 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.66796105 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.83369805 |
2 | MP0002396_abnormal_hematopoietic_system | 3.62137790 |
3 | MP0001800_abnormal_humoral_immune | 2.86958797 |
4 | MP0004808_abnormal_hematopoietic_stem | 2.80940554 |
5 | MP0000685_abnormal_immune_system | 2.76395239 |
6 | MP0005671_abnormal_response_to | 2.64897463 |
7 | MP0008004_abnormal_stomach_pH | 2.62540079 |
8 | MP0002398_abnormal_bone_marrow | 2.54545813 |
9 | MP0002452_abnormal_antigen_presenting | 2.50324766 |
10 | MP0005464_abnormal_platelet_physiology | 2.45925554 |
11 | MP0005387_immune_system_phenotype | 2.42770855 |
12 | MP0001790_abnormal_immune_system | 2.42770855 |
13 | MP0003436_decreased_susceptibility_to | 2.41051994 |
14 | MP0008057_abnormal_DNA_replication | 2.38609855 |
15 | MP0009785_altered_susceptibility_to | 2.37550176 |
16 | MP0010094_abnormal_chromosome_stability | 2.36352063 |
17 | MP0005397_hematopoietic_system_phenotyp | 2.35243783 |
18 | MP0001545_abnormal_hematopoietic_system | 2.35243783 |
19 | MP0002420_abnormal_adaptive_immunity | 2.30122320 |
20 | MP0005000_abnormal_immune_tolerance | 2.27899569 |
21 | MP0001819_abnormal_immune_cell | 2.27432201 |
22 | MP0003693_abnormal_embryo_hatching | 2.26641190 |
23 | MP0002723_abnormal_immune_serum | 2.25362689 |
24 | MP0000689_abnormal_spleen_morphology | 2.20521887 |
25 | MP0009278_abnormal_bone_marrow | 2.17005904 |
26 | MP0003303_peritoneal_inflammation | 2.16713450 |
27 | MP0005025_abnormal_response_to | 2.15703858 |
28 | MP0000716_abnormal_immune_system | 2.14762822 |
29 | MP0002419_abnormal_innate_immunity | 2.08008522 |
30 | MP0002722_abnormal_immune_system | 2.07996365 |
31 | MP0000465_gastrointestinal_hemorrhage | 2.02751631 |
32 | MP0003763_abnormal_thymus_physiology | 1.96385170 |
33 | MP0002429_abnormal_blood_cell | 1.95301783 |
34 | MP0006054_spinal_hemorrhage | 1.92018887 |
35 | MP0002166_altered_tumor_susceptibility | 1.87996115 |
36 | MP0002148_abnormal_hypersensitivity_rea | 1.86043529 |
37 | MP0003111_abnormal_nucleus_morphology | 1.83488320 |
38 | MP0003077_abnormal_cell_cycle | 1.81294066 |
39 | MP0005451_abnormal_body_composition | 1.78244955 |
40 | MP0005174_abnormal_tail_pigmentation | 1.77675518 |
41 | MP0004510_myositis | 1.76210091 |
42 | MP0000490_abnormal_crypts_of | 1.73704300 |
43 | MP0000703_abnormal_thymus_morphology | 1.70077316 |
44 | MP0002405_respiratory_system_inflammati | 1.69246713 |
45 | MP0010155_abnormal_intestine_physiology | 1.68409362 |
46 | MP0004883_abnormal_blood_vessel | 1.59543752 |
47 | MP0009333_abnormal_splenocyte_physiolog | 1.57887483 |
48 | MP0008058_abnormal_DNA_repair | 1.56304834 |
49 | MP0002998_abnormal_bone_remodeling | 1.55827826 |
50 | MP0008007_abnormal_cellular_replicative | 1.53558101 |
51 | MP0001853_heart_inflammation | 1.53045293 |
52 | MP0003300_gastrointestinal_ulcer | 1.52570896 |
53 | MP0001873_stomach_inflammation | 1.51333933 |
54 | MP0003075_altered_response_to | 1.50655268 |
55 | MP0001845_abnormal_inflammatory_respons | 1.48772084 |
56 | MP0003724_increased_susceptibility_to | 1.46444963 |
57 | MP0005075_abnormal_melanosome_morpholog | 1.46400663 |
58 | MP0002006_tumorigenesis | 1.46330874 |
59 | MP0002132_abnormal_respiratory_system | 1.45225976 |
60 | MP0010307_abnormal_tumor_latency | 1.40152939 |
61 | MP0004957_abnormal_blastocyst_morpholog | 1.39744334 |
62 | MP0002019_abnormal_tumor_incidence | 1.39440630 |
63 | MP0010352_gastrointestinal_tract_polyps | 1.32573547 |
64 | MP0003091_abnormal_cell_migration | 1.32012637 |
65 | MP0005164_abnormal_response_to | 1.31796342 |
66 | MP0002095_abnormal_skin_pigmentation | 1.30600136 |
67 | MP0003656_abnormal_erythrocyte_physiolo | 1.27640060 |
68 | MP0002877_abnormal_melanocyte_morpholog | 1.23555822 |
69 | MP0004947_skin_inflammation | 1.18970306 |
70 | MP0003690_abnormal_glial_cell | 1.16308177 |
71 | MP0000015_abnormal_ear_pigmentation | 1.12692317 |
72 | MP0003866_abnormal_defecation | 1.12547604 |
73 | MP0008469_abnormal_protein_level | 1.09936610 |
74 | MP0001851_eye_inflammation | 1.08851562 |
75 | MP0006082_CNS_inflammation | 1.07264581 |
76 | MP0000249_abnormal_blood_vessel | 1.07152122 |
77 | MP0003183_abnormal_peptide_metabolism | 1.06367861 |
78 | MP0003191_abnormal_cellular_cholesterol | 1.05335608 |
79 | MP0003943_abnormal_hepatobiliary_system | 1.04426624 |
80 | MP0005083_abnormal_biliary_tract | 1.03674593 |
81 | MP0000604_amyloidosis | 1.02275663 |
82 | MP0005310_abnormal_salivary_gland | 1.00343238 |
83 | MP0000313_abnormal_cell_death | 0.99565367 |
84 | MP0004147_increased_porphyrin_level | 0.98689065 |
85 | MP0001986_abnormal_taste_sensitivity | 0.98291114 |
86 | MP0002332_abnormal_exercise_endurance | 0.94543609 |
87 | MP0008260_abnormal_autophagy | 0.94538179 |
88 | MP0001533_abnormal_skeleton_physiology | 0.93889633 |
89 | MP0005167_abnormal_blood-brain_barrier | 0.91935919 |
90 | MP0009764_decreased_sensitivity_to | 0.89011809 |
91 | MP0003172_abnormal_lysosome_physiology | 0.86964924 |
92 | MP0005390_skeleton_phenotype | 0.86506797 |
93 | MP0000350_abnormal_cell_proliferation | 0.86021292 |
94 | MP0000858_altered_metastatic_potential | 0.84763696 |
95 | MP0005166_decreased_susceptibility_to | 0.83179276 |
96 | MP0008874_decreased_physiological_sensi | 0.82955196 |
97 | MP0002928_abnormal_bile_duct | 0.82876783 |
98 | MP0005084_abnormal_gallbladder_morpholo | 0.81574273 |
99 | MP0003795_abnormal_bone_structure | 0.79344030 |
100 | MP0003828_pulmonary_edema | 0.76461903 |
101 | MP0003786_premature_aging | 0.76232839 |
102 | MP0003787_abnormal_imprinting | 0.76175619 |
103 | MP0008877_abnormal_DNA_methylation | 0.75645080 |
104 | MP0000569_abnormal_digit_pigmentation | 0.72941004 |
105 | MP0002139_abnormal_hepatobiliary_system | 0.71650416 |
106 | MP0005165_increased_susceptibility_to | 0.71367777 |
107 | MP0002933_joint_inflammation | 0.70343272 |
108 | MP0000598_abnormal_liver_morphology | 0.69617451 |
109 | MP0009763_increased_sensitivity_to | 0.68757208 |
110 | MP0003448_altered_tumor_morphology | 0.66411707 |
111 | MP0003453_abnormal_keratinocyte_physiol | 0.65934497 |
112 | MP0002693_abnormal_pancreas_physiology | 0.65151410 |
113 | MP0005381_digestive/alimentary_phenotyp | 0.64920843 |
114 | MP0003567_abnormal_fetal_cardiomyocyte | 0.63814609 |
115 | MP0001663_abnormal_digestive_system | 0.63310792 |
116 | MP0005365_abnormal_bile_salt | 0.62908670 |
117 | MP0000371_diluted_coat_color | 0.60983046 |
118 | MP0005535_abnormal_body_temperature | 0.60855321 |
119 | MP0005058_abnormal_lysosome_morphology | 0.60819445 |
120 | MP0009765_abnormal_xenobiotic_induced | 0.60635782 |
121 | MP0003638_abnormal_response/metabolism_ | 0.59953672 |
122 | MP0010329_abnormal_lipoprotein_level | 0.59454530 |
123 | MP0001915_intracranial_hemorrhage | 0.58884680 |
124 | MP0001879_abnormal_lymphatic_vessel | 0.58425794 |
125 | MP0000609_abnormal_liver_physiology | 0.58300718 |
126 | MP0000230_abnormal_systemic_arterial | 0.58007793 |
127 | MP0008873_increased_physiological_sensi | 0.57977302 |
128 | MP0009840_abnormal_foam_cell | 0.57018381 |
129 | MP0005319_abnormal_enzyme/_coenzyme | 0.56950524 |
130 | MP0003566_abnormal_cell_adhesion | 0.56581662 |
131 | MP0004264_abnormal_extraembryonic_tissu | 0.55847290 |
132 | MP0005076_abnormal_cell_differentiation | 0.55310583 |
133 | MP0001958_emphysema | 0.55101255 |
134 | MP0000343_altered_response_to | 0.52881610 |
135 | MP0002075_abnormal_coat/hair_pigmentati | 0.52586814 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Agammaglobulinemia (HP:0004432) | 5.26535799 |
2 | Cellulitis (HP:0100658) | 5.12823886 |
3 | Menorrhagia (HP:0000132) | 4.79085513 |
4 | Increased mean platelet volume (HP:0011877) | 4.55315502 |
5 | IgM deficiency (HP:0002850) | 4.46875024 |
6 | Recurrent viral infections (HP:0004429) | 4.25445553 |
7 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.02776543 |
8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.02776543 |
9 | Abnormality of glycolipid metabolism (HP:0010969) | 4.02776543 |
10 | Meningitis (HP:0001287) | 4.02741366 |
11 | Recurrent abscess formation (HP:0002722) | 3.92379103 |
12 | Thrombocytosis (HP:0001894) | 3.85499158 |
13 | Abnormality of B cell number (HP:0010975) | 3.83783315 |
14 | B lymphocytopenia (HP:0010976) | 3.83783315 |
15 | Dysostosis multiplex (HP:0000943) | 3.81795826 |
16 | Chronic otitis media (HP:0000389) | 3.75572097 |
17 | Recurrent bronchitis (HP:0002837) | 3.72985883 |
18 | Prolonged bleeding time (HP:0003010) | 3.71054181 |
19 | Panhypogammaglobulinemia (HP:0003139) | 3.70181763 |
20 | Recurrent bacterial skin infections (HP:0005406) | 3.69023975 |
21 | Petechiae (HP:0000967) | 3.68101381 |
22 | Recurrent fungal infections (HP:0002841) | 3.60039050 |
23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.57266883 |
24 | Papilloma (HP:0012740) | 3.50225051 |
25 | Verrucae (HP:0200043) | 3.50225051 |
26 | Vacuolated lymphocytes (HP:0001922) | 3.48861721 |
27 | Myositis (HP:0100614) | 3.35258381 |
28 | Thyroiditis (HP:0100646) | 3.29073403 |
29 | Eczematoid dermatitis (HP:0000976) | 3.23569647 |
30 | Osteomyelitis (HP:0002754) | 3.22212886 |
31 | Increased cerebral lipofuscin (HP:0011813) | 3.17093484 |
32 | Stomatitis (HP:0010280) | 3.10978317 |
33 | Abnormality of T cell physiology (HP:0011840) | 3.09312861 |
34 | Gastrointestinal inflammation (HP:0004386) | 3.05995470 |
35 | Inflammation of the large intestine (HP:0002037) | 3.03980246 |
36 | Colitis (HP:0002583) | 3.03807654 |
37 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.97727502 |
38 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.97584308 |
39 | Aplastic anemia (HP:0001915) | 2.96738695 |
40 | Polycythemia (HP:0001901) | 2.92884083 |
41 | Reticulocytopenia (HP:0001896) | 2.86480380 |
42 | Chronic sinusitis (HP:0011109) | 2.80571395 |
43 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.79437186 |
44 | Abnormality of T cells (HP:0002843) | 2.78975512 |
45 | Epistaxis (HP:0000421) | 2.78638208 |
46 | Gastrointestinal infarctions (HP:0005244) | 2.73862450 |
47 | Mucopolysacchariduria (HP:0008155) | 2.72018962 |
48 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.72018962 |
49 | Peritonitis (HP:0002586) | 2.71826698 |
50 | Spontaneous hematomas (HP:0007420) | 2.71733351 |
51 | Abnormality of the common coagulation pathway (HP:0010990) | 2.71523351 |
52 | Abnormality of the fingertips (HP:0001211) | 2.70664240 |
53 | Encephalitis (HP:0002383) | 2.68866039 |
54 | Vasculitis (HP:0002633) | 2.66063424 |
55 | Abnormal platelet function (HP:0011869) | 2.65562476 |
56 | Impaired platelet aggregation (HP:0003540) | 2.65562476 |
57 | Myocardial infarction (HP:0001658) | 2.65510626 |
58 | Recurrent pneumonia (HP:0006532) | 2.65070209 |
59 | Recurrent skin infections (HP:0001581) | 2.64476152 |
60 | Episodic fever (HP:0001954) | 2.64161152 |
61 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.63189626 |
62 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.63189626 |
63 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.63189626 |
64 | Hypoplasia of the thymus (HP:0000778) | 2.62724051 |
65 | Lymphopenia (HP:0001888) | 2.62719283 |
66 | Mediastinal lymphadenopathy (HP:0100721) | 2.61744303 |
67 | IgG deficiency (HP:0004315) | 2.60492944 |
68 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.59887757 |
69 | Myelodysplasia (HP:0002863) | 2.58849312 |
70 | Conjunctival telangiectasia (HP:0000524) | 2.58045031 |
71 | Sepsis (HP:0100806) | 2.57879903 |
72 | Abnormal number of erythroid precursors (HP:0012131) | 2.56969781 |
73 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.56179621 |
74 | Loss of speech (HP:0002371) | 2.54591541 |
75 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.53869767 |
76 | Increased serum ferritin (HP:0003281) | 2.53250064 |
77 | Abnormality of iron homeostasis (HP:0011031) | 2.51671802 |
78 | Gastrointestinal stroma tumor (HP:0100723) | 2.51517706 |
79 | Gingival bleeding (HP:0000225) | 2.49131119 |
80 | Recurrent lower respiratory tract infections (HP:0002783) | 2.45929065 |
81 | Amyloidosis (HP:0011034) | 2.44891478 |
82 | Optic neuritis (HP:0100653) | 2.44255077 |
83 | Retrobulbar optic neuritis (HP:0100654) | 2.44255077 |
84 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.44013769 |
85 | Recurrent cutaneous fungal infections (HP:0011370) | 2.44013769 |
86 | Orchitis (HP:0100796) | 2.43121639 |
87 | Urticaria (HP:0001025) | 2.42417854 |
88 | Obstructive lung disease (HP:0006536) | 2.41768647 |
89 | Chronic obstructive pulmonary disease (HP:0006510) | 2.41768647 |
90 | Recurrent sinusitis (HP:0011108) | 2.40296364 |
91 | Lymphoma (HP:0002665) | 2.40044543 |
92 | Bruising susceptibility (HP:0000978) | 2.39515075 |
93 | Chromsome breakage (HP:0040012) | 2.39364752 |
94 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.39357160 |
95 | Neutropenia (HP:0001875) | 2.37944227 |
96 | Hypochromic anemia (HP:0001931) | 2.36922036 |
97 | Volvulus (HP:0002580) | 2.36779741 |
98 | Abnormal platelet volume (HP:0011876) | 2.36201988 |
99 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.35979121 |
100 | Gingivitis (HP:0000230) | 2.35294566 |
101 | Periodontitis (HP:0000704) | 2.35173450 |
102 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.33019393 |
103 | IgA deficiency (HP:0002720) | 2.32569948 |
104 | Granulocytopenia (HP:0001913) | 2.28007953 |
105 | Abnormality of the prostate (HP:0008775) | 2.26479191 |
106 | T lymphocytopenia (HP:0005403) | 2.26465122 |
107 | Pulmonary embolism (HP:0002204) | 2.23935996 |
108 | Autoimmune thrombocytopenia (HP:0001973) | 2.23782812 |
109 | Disinhibition (HP:0000734) | 2.22819710 |
110 | Skin rash (HP:0000988) | 2.21627920 |
111 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.20497605 |
112 | Acanthocytosis (HP:0001927) | 2.19188267 |
113 | Facial diplegia (HP:0001349) | 2.19169703 |
114 | Cutaneous melanoma (HP:0012056) | 2.17877460 |
115 | Systemic lupus erythematosus (HP:0002725) | 2.17622961 |
116 | Abnormality of T cell number (HP:0011839) | 2.17405071 |
117 | Arterial thrombosis (HP:0004420) | 2.16636891 |
118 | Acute myeloid leukemia (HP:0004808) | 2.15472377 |
119 | Acute lymphatic leukemia (HP:0006721) | 2.14454889 |
120 | Hematochezia (HP:0002573) | 2.13753091 |
121 | Hyperlipoproteinemia (HP:0010980) | 2.13608266 |
122 | Eosinophilia (HP:0001880) | 2.12337976 |
123 | Pulmonary infiltrates (HP:0002113) | 2.09370448 |
124 | Pallor (HP:0000980) | 2.09037247 |
125 | Hepatosplenomegaly (HP:0001433) | 2.07433516 |
126 | Chest pain (HP:0100749) | 2.07183109 |
127 | Poikilocytosis (HP:0004447) | 2.07164022 |
128 | Abnormality of macrophages (HP:0004311) | 2.04608397 |
129 | Severe combined immunodeficiency (HP:0004430) | 2.04017947 |
130 | Combined immunodeficiency (HP:0005387) | 2.03499377 |
131 | Leukocytosis (HP:0001974) | 2.00710792 |
132 | Keratoconjunctivitis sicca (HP:0001097) | 2.00075301 |
133 | Purpura (HP:0000979) | 1.98497969 |
134 | Skin ulcer (HP:0200042) | 1.97174879 |
135 | Joint hemorrhage (HP:0005261) | 1.96979523 |
136 | Amaurosis fugax (HP:0100576) | 1.96453700 |
137 | Bronchitis (HP:0012387) | 1.96035098 |
138 | Poikiloderma (HP:0001029) | 1.95185497 |
139 | Hemoptysis (HP:0002105) | 1.94171211 |
140 | Mucosal telangiectasiae (HP:0100579) | 1.93368915 |
141 | Leukopenia (HP:0001882) | 1.93306209 |
142 | Interstitial pulmonary disease (HP:0006530) | 1.92562612 |
143 | Clubbing of toes (HP:0100760) | 1.91475508 |
144 | Vertigo (HP:0002321) | 1.89331443 |
145 | Increased IgE level (HP:0003212) | 1.89197127 |
146 | Thrombophlebitis (HP:0004418) | 1.88879428 |
147 | Increased IgM level (HP:0003496) | 1.85448200 |
148 | Abnormality of the peritoneum (HP:0002585) | 1.82817024 |
149 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.80483620 |
150 | Acne (HP:0001061) | 1.79133597 |
151 | Dyschromatopsia (HP:0007641) | 1.78080004 |
152 | Autoimmune hemolytic anemia (HP:0001890) | 1.73480942 |
153 | Splenomegaly (HP:0001744) | 1.72866121 |
154 | Ventricular fibrillation (HP:0001663) | 1.72010324 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 3.63905995 |
2 | EEF2K | 3.63153728 |
3 | MAP3K10 | 3.23433827 |
4 | BTK | 2.50886388 |
5 | GRK6 | 2.35447910 |
6 | BMPR2 | 2.35356627 |
7 | IRAK4 | 2.17091882 |
8 | FGR | 2.06607506 |
9 | BLK | 2.02235780 |
10 | FLT3 | 1.97944709 |
11 | RPS6KB2 | 1.95771075 |
12 | SYK | 1.95340729 |
13 | PKN2 | 1.93525533 |
14 | ERN1 | 1.90237886 |
15 | CSF1R | 1.84658604 |
16 | KIT | 1.81455654 |
17 | TEC | 1.80758741 |
18 | NEK2 | 1.75839223 |
19 | TAOK3 | 1.71934996 |
20 | CDC7 | 1.68857512 |
21 | GRK7 | 1.67161466 |
22 | PIM1 | 1.63854010 |
23 | PIK3CG | 1.61963646 |
24 | STK10 | 1.59291893 |
25 | STK4 | 1.55999619 |
26 | TYK2 | 1.41074806 |
27 | JAK3 | 1.40449993 |
28 | ZAP70 | 1.40276662 |
29 | MAP3K14 | 1.39833233 |
30 | PRPF4B | 1.38771845 |
31 | MATK | 1.30945731 |
32 | CDK4 | 1.28606542 |
33 | BMX | 1.27566168 |
34 | CLK1 | 1.26970934 |
35 | TGFBR1 | 1.25072696 |
36 | LRRK2 | 1.24155422 |
37 | CAMKK2 | 1.23006272 |
38 | WEE1 | 1.22500047 |
39 | LYN | 1.21486397 |
40 | PASK | 1.21148075 |
41 | TGFBR2 | 1.21085128 |
42 | MAP3K3 | 1.20779211 |
43 | ZAK | 1.19938068 |
44 | IRAK3 | 1.19830175 |
45 | SIK2 | 1.17814345 |
46 | BRD4 | 1.17376611 |
47 | ATR | 1.16728526 |
48 | MAP2K3 | 1.16512547 |
49 | MAP3K1 | 1.16389931 |
50 | FES | 1.15634443 |
51 | IRAK1 | 1.14881826 |
52 | YES1 | 1.12151577 |
53 | TBK1 | 1.11242418 |
54 | IKBKB | 1.10736171 |
55 | ACVR1B | 1.09990057 |
56 | CDK12 | 1.08934591 |
57 | IKBKE | 1.06591417 |
58 | TNK2 | 1.05994971 |
59 | MAP3K11 | 1.05430420 |
60 | RIPK4 | 1.05376219 |
61 | TLK1 | 1.05183326 |
62 | EPHB1 | 1.03106338 |
63 | PDK1 | 1.02990489 |
64 | TAOK1 | 1.01533644 |
65 | SCYL2 | 1.00405972 |
66 | PDPK1 | 0.99815032 |
67 | HCK | 0.99580178 |
68 | EPHA3 | 0.99260735 |
69 | VRK1 | 0.98347001 |
70 | EIF2AK3 | 0.97741365 |
71 | MKNK1 | 0.96335581 |
72 | TRPM7 | 0.96170189 |
73 | PTK2B | 0.95195410 |
74 | FGFR3 | 0.92090463 |
75 | MAPK11 | 0.91641760 |
76 | MAP3K2 | 0.91577540 |
77 | IRAK2 | 0.90764668 |
78 | TXK | 0.89733285 |
79 | BRSK2 | 0.88133639 |
80 | PIM2 | 0.88113429 |
81 | ADRBK2 | 0.86467570 |
82 | CDK6 | 0.84344606 |
83 | CDC42BPA | 0.84316672 |
84 | BUB1 | 0.83456427 |
85 | LCK | 0.83078493 |
86 | TAOK2 | 0.80364621 |
87 | DYRK1B | 0.79008540 |
88 | MAP3K5 | 0.78362107 |
89 | CSK | 0.76277336 |
90 | STK24 | 0.73644248 |
91 | ITK | 0.72680588 |
92 | HIPK2 | 0.72225729 |
93 | MAPK4 | 0.71774358 |
94 | MAP3K8 | 0.71363138 |
95 | CAMK1D | 0.70035444 |
96 | MOS | 0.69816231 |
97 | MARK2 | 0.69579598 |
98 | KSR2 | 0.68827290 |
99 | AURKB | 0.68168604 |
100 | RET | 0.67996585 |
101 | MAPKAPK3 | 0.67915187 |
102 | JAK1 | 0.67429960 |
103 | FGFR4 | 0.64801985 |
104 | CDK9 | 0.63980543 |
105 | MKNK2 | 0.63053966 |
106 | CDK7 | 0.62651962 |
107 | CAMK1G | 0.62121090 |
108 | CHUK | 0.61529247 |
109 | MAP3K13 | 0.59958832 |
110 | CCNB1 | 0.59401697 |
111 | STK16 | 0.58405371 |
112 | PDGFRB | 0.57622738 |
113 | RPS6KA4 | 0.56070565 |
114 | EIF2AK1 | 0.52258922 |
115 | DYRK3 | 0.51970361 |
116 | RPS6KB1 | 0.51805772 |
117 | TESK2 | 0.50537701 |
118 | ALK | 0.50460807 |
119 | JAK2 | 0.49371673 |
120 | KDR | 0.49159807 |
121 | SIK3 | 0.48484278 |
122 | DDR2 | 0.48167287 |
123 | PLK4 | 0.48014722 |
124 | SRPK1 | 0.47760285 |
125 | NLK | 0.47710352 |
126 | NEK9 | 0.47483157 |
127 | RPS6KA6 | 0.47245924 |
128 | MARK3 | 0.46293257 |
129 | FYN | 0.46012662 |
130 | BRSK1 | 0.45847120 |
131 | MAP2K4 | 0.45796367 |
132 | CHEK1 | 0.45434781 |
133 | TRIB3 | 0.45218178 |
134 | PAK4 | 0.44811458 |
135 | RAF1 | 0.44484371 |
136 | MAP3K6 | 0.43995989 |
137 | PLK1 | 0.42446217 |
138 | MAP3K12 | 0.42256778 |
139 | SGK3 | 0.41341277 |
140 | MAP3K7 | 0.39985356 |
141 | RPS6KC1 | 0.39767753 |
142 | KSR1 | 0.39090972 |
143 | PRKCQ | 0.38918101 |
144 | MAPK7 | 0.38180035 |
145 | GRK5 | 0.36917697 |
146 | SGK2 | 0.33401995 |
147 | MAPK12 | 0.33297007 |
148 | WNK1 | 0.31711676 |
149 | ABL1 | 0.31460203 |
150 | MAP2K1 | 0.31381615 |
151 | PTK6 | 0.31034201 |
152 | PRKCD | 0.30205905 |
153 | EPHB2 | 0.29806723 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 3.80499617 |
2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.50545737 |
3 | Mismatch repair_Homo sapiens_hsa03430 | 2.87161983 |
4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.78378792 |
5 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.75428077 |
6 | Base excision repair_Homo sapiens_hsa03410 | 2.72215211 |
7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.12422055 |
8 | Ribosome_Homo sapiens_hsa03010 | 2.09473402 |
9 | Homologous recombination_Homo sapiens_hsa03440 | 2.03686217 |
10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.03144267 |
11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.89607315 |
12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.86996699 |
13 | Lysosome_Homo sapiens_hsa04142 | 1.78417052 |
14 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.73145696 |
15 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.70175476 |
16 | Measles_Homo sapiens_hsa05162 | 1.64836961 |
17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.64407757 |
18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.63666410 |
19 | Cell cycle_Homo sapiens_hsa04110 | 1.61967691 |
20 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.59844907 |
21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.56423016 |
22 | Spliceosome_Homo sapiens_hsa03040 | 1.56083647 |
23 | Phagosome_Homo sapiens_hsa04145 | 1.52666170 |
24 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.51813386 |
25 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.47429398 |
26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.45000454 |
27 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.44700480 |
28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.43729342 |
29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.43581887 |
30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.43362769 |
31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.35664151 |
32 | Legionellosis_Homo sapiens_hsa05134 | 1.35375344 |
33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.35089460 |
34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.32275640 |
35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.29771838 |
36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.24722828 |
37 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.20968277 |
38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.18838990 |
39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.16909976 |
40 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.16440815 |
41 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.15105082 |
42 | Influenza A_Homo sapiens_hsa05164 | 1.14067571 |
43 | Hepatitis B_Homo sapiens_hsa05161 | 1.13685468 |
44 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.11687723 |
45 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.11403006 |
46 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.10248108 |
47 | Other glycan degradation_Homo sapiens_hsa00511 | 1.08781222 |
48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.08404576 |
49 | Platelet activation_Homo sapiens_hsa04611 | 1.07858577 |
50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.07668391 |
51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.04886620 |
52 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.03834346 |
53 | Apoptosis_Homo sapiens_hsa04210 | 1.02553242 |
54 | Shigellosis_Homo sapiens_hsa05131 | 1.02413379 |
55 | RNA transport_Homo sapiens_hsa03013 | 1.00736485 |
56 | Tuberculosis_Homo sapiens_hsa05152 | 0.99503903 |
57 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.98397082 |
58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.97705478 |
59 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.97559548 |
60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.94928925 |
61 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.93958031 |
62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92920608 |
63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.92720018 |
64 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.91252072 |
65 | Pertussis_Homo sapiens_hsa05133 | 0.90398927 |
66 | RNA degradation_Homo sapiens_hsa03018 | 0.90387729 |
67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89914311 |
68 | Amoebiasis_Homo sapiens_hsa05146 | 0.89907802 |
69 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.88683039 |
70 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.88624307 |
71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.87490096 |
72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.86309568 |
73 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.86277324 |
74 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.85976901 |
75 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.85502260 |
76 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.83831727 |
77 | Asthma_Homo sapiens_hsa05310 | 0.82904223 |
78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81789732 |
79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79747222 |
80 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.79718905 |
81 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79230179 |
82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78615161 |
83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78181947 |
84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.76628700 |
85 | Allograft rejection_Homo sapiens_hsa05330 | 0.73948360 |
86 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71899381 |
87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71322458 |
88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69440050 |
89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69272600 |
90 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.67152401 |
91 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.66922553 |
92 | Malaria_Homo sapiens_hsa05144 | 0.65848485 |
93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65756468 |
94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65487010 |
95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.64399748 |
96 | RNA polymerase_Homo sapiens_hsa03020 | 0.63910003 |
97 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.63424470 |
98 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.63178872 |
99 | Alcoholism_Homo sapiens_hsa05034 | 0.61618982 |
100 | Bladder cancer_Homo sapiens_hsa05219 | 0.61514512 |
101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60742128 |
102 | Endocytosis_Homo sapiens_hsa04144 | 0.60233081 |
103 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.60103824 |
104 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59278164 |
105 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59234018 |
106 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.58521892 |
107 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58097932 |
108 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.57882462 |
109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57078964 |
110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56942428 |
111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56382333 |
112 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.55298943 |
113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54547469 |
114 | Hepatitis C_Homo sapiens_hsa05160 | 0.52803298 |
115 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52399077 |
116 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52069267 |
117 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51969262 |
118 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51317111 |
119 | ABC transporters_Homo sapiens_hsa02010 | 0.49337263 |
120 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48142496 |
121 | Sulfur relay system_Homo sapiens_hsa04122 | 0.48076810 |
122 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47867565 |
123 | Purine metabolism_Homo sapiens_hsa00230 | 0.46022019 |
124 | Basal transcription factors_Homo sapiens_hsa03022 | 0.45921434 |
125 | Salmonella infection_Homo sapiens_hsa05132 | 0.45420988 |
126 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.45289573 |
127 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44851607 |
128 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44364302 |
129 | Focal adhesion_Homo sapiens_hsa04510 | 0.43716760 |
130 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.43441029 |
131 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43208972 |
132 | Lysine degradation_Homo sapiens_hsa00310 | 0.39513351 |
133 | Thyroid cancer_Homo sapiens_hsa05216 | 0.39068721 |
134 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.37730773 |
135 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36149614 |
136 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.35759964 |
137 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35401341 |
138 | Colorectal cancer_Homo sapiens_hsa05210 | 0.35364254 |
139 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.35161650 |
140 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.35009490 |
141 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.34294536 |